Cypherpunk Technologies (CYPH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.57, -14.90% vs the prior close of $3.02.
- Volume 11.57M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CYPH slides 14.9% to $2.57, a 1-month low. Closed at $2.57, -14.90% vs the prior close of $3.02. Day range $2.50β$3.00, opened at $2.91.
CYPH daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β CYPH slides 14.9% to $2.57, a 1-month low
- Closed at $2.57, -14.90% vs the prior close of $3.02. Day range $2.50β$3.00, opened at $2.91.
- Volume was 11.57M shares, 0.9x its 50-day average of 13.43M.
- Price is +11.7% vs its 50-day average ($2.30) and +116.5% vs its 200-day average ($1.19).
- 52-week range $0.39β$4.19; today's close sits at 57% of that range, 38.7% below the 52-week high.
Oct 15, 2026 β CYPH jumps 15.3% to $3.02
- Closed at $3.02, +15.27% vs the prior close of $2.62. Day range $2.38β$3.09, opened at $2.42.
- Volume was 16.35M shares, 1.2x its 50-day average of 13.12M.
- Price is +33.5% vs its 50-day average ($2.26) and +155.7% vs its 200-day average ($1.18).
- 52-week range $0.39β$4.19; today's close sits at 69% of that range, 27.9% below the 52-week high.
Oct 14, 2026 β CYPH slides 7.7% to $2.62, 3 down days in a row
- Closed at $2.62, -7.75% vs the prior close of $2.84. Day range $2.57β$2.82, opened at $2.71.
- Volume was 8.20M shares, 0.6x its 50-day average of 12.99M.
- Price is +18.2% vs its 50-day average ($2.22) and +123.6% vs its 200-day average ($1.17).
- 52-week range $0.39β$4.19; today's close sits at 59% of that range, 37.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 β CYPH dips 2.1% to $2.84
- Closed at $2.84, -2.07% vs the prior close of $2.90. Day range $2.70β$2.84, opened at $2.79.
- Volume was 7.40M shares, 0.6x its 50-day average of 12.86M β lighter than usual.
- Price is +30.4% vs its 50-day average ($2.18) and +143.9% vs its 200-day average ($1.16).
- 52-week range $0.39β$4.19; today's close sits at 64% of that range, 32.2% below the 52-week high.
Oct 12, 2026 β CYPH dips 1.4% to $2.90
- Closed at $2.90, -1.36% vs the prior close of $2.94. Day range $2.86β$3.23, opened at $3.01.
- Volume was 9.39M shares, 0.7x its 50-day average of 12.69M.
- Price is +35.9% vs its 50-day average ($2.13) and +150.8% vs its 200-day average ($1.16).
- 52-week range $0.39β$4.19; today's close sits at 66% of that range, 30.8% below the 52-week high.
Oct 9, 2026 β CYPH jumps 4.6% to $2.94
- Closed at $2.94, +4.63% vs the prior close of $2.81. Day range $2.88β$3.17, opened at $2.97.
- Volume was 10.26M shares, 0.8x its 50-day average of 12.50M.
- Price is +40.8% vs its 50-day average ($2.09) and +156.2% vs its 200-day average ($1.15).
- 52-week range $0.39β$4.19; today's close sits at 67% of that range, 29.8% below the 52-week high.
Oct 8, 2026 β CYPH slides 7.9% to $2.81
- Closed at $2.81, -7.87% vs the prior close of $3.05. Day range $2.55β$2.84, opened at $2.80.
- Volume was 14.77M shares, 1.2x its 50-day average of 12.23M.
- Price is +37.6% vs its 50-day average ($2.04) and +146.8% vs its 200-day average ($1.14).
- 52-week range $0.39β$4.19; today's close sits at 64% of that range, 32.9% below the 52-week high.
Oct 7, 2026 β CYPH slides 6.4% to $3.05
- Closed at $3.05, -6.44% vs the prior close of $3.26. Day range $2.93β$3.09, opened at $2.97.
- Volume was 8.11M shares, 0.7x its 50-day average of 12.10M.
- Price is +52.7% vs its 50-day average ($2.00) and +169.7% vs its 200-day average ($1.13).
- 52-week range $0.39β$4.19; today's close sits at 70% of that range, 27.2% below the 52-week high.
Oct 6, 2026 β CYPH rises 2.8% to $3.26, 3 up days in a row
- Closed at $3.26, +2.84% vs the prior close of $3.17. Day range $3.09β$3.40, opened at $3.17.
- Volume was 13.08M shares, 1.1x its 50-day average of 11.86M.
- Price is +67.3% vs its 50-day average ($1.95) and +191.0% vs its 200-day average ($1.12).
- 52-week range $0.39β$4.19; today's close sits at 76% of that range, 22.2% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 β CYPH jumps 4.6% to $3.17
- Closed at $3.17, +4.62% vs the prior close of $3.03. Day range $2.88β$3.19, opened at $3.01.
- Volume was 14.39M shares, 1.2x its 50-day average of 11.58M.
- Price is +67.2% vs its 50-day average ($1.90) and +185.9% vs its 200-day average ($1.11).
- 52-week range $0.39β$4.19; today's close sits at 73% of that range, 24.3% below the 52-week high.
Oct 2, 2026 β CYPH jumps 3.8% to $3.03
- Closed at $3.03, +3.77% vs the prior close of $2.92. Day range $3.01β$3.42, opened at $3.21.
- Volume was 15.38M shares, 1.4x its 50-day average of 11.32M.
- Price is +64.2% vs its 50-day average ($1.85) and +175.7% vs its 200-day average ($1.10).
- 52-week range $0.39β$4.19; today's close sits at 69% of that range, 27.7% below the 52-week high.
CYPH latest news & SEC filings
Every SEC filing by or about CYPH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Winklevoss Capital Fund, Llc & Winklevoss Treasury Investments, Llc & Winklevoss Tyler Howard & Winklevoss Cameron Howard & Winklevoss Capital Management, Llc exercised options for 4,938,801 shares at $0.00 (β$4.94K) on Oct 12, 2026; now holds 29,793,414
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Mcevoy William Patrick Iii exercised options for 4,938,801 shares at $0.00 (β$4.94K) on Oct 12, 2026; now holds 29,793,414
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Sep 25, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Oei Khing Djien sold 168,750 shares at $3.92 (β$661.50K) on Sep 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Martin Patricia A. sold 50,000 shares at $3.86 (β$193.00K) on Sep 23, 2026; now holds 118,750
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Sep 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Aug 27, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Dietz Thomas John sold 20,000 shares at $1.72 (β$34.40K) on Aug 26, 2026
- Dietz Thomas John sold 20,000 shares at $1.72 (β$34.40K) on Aug 26, 2026
- Dietz Thomas John sold 20,000 shares at $1.72 (β$34.40K) on Aug 26, 2026
- Dietz Thomas John sold 20,000 shares at $1.72 (β$34.40K) on Aug 26, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 Β· Form SCHEDULE 13D/A β Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 18, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
- Item 8.01 β Reported other events the company considers important.
Aug 12, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $39.39M (prior year -$16.64M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.18 (prior year -$0.40) (swung to profit vs Jun 30, 2025)
Aug 12, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 8.01 β Reported other events the company considers important.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 21, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.01 β Stock exchange listing notice or transfer of listing.
Jun 22, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
Things to know before you trade CYPH
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 16, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 7.07% (largest 19.7%). That is a volatile stock.
- Liquidity: about 15.64M shares (β$40.18M) trade per day on average.
- 52-week position: $2.57 vs a range of $0.39β$4.19 (57% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Khing Djien Oei sold 168,750 shares on Sep 25, 2026.
- Latest filings: 8-K Sep 22, 2026; 8-K Sep 2, 2026; 8-K Aug 18, 2026.
- Share count: 107.76M shares outstanding (Aug 10, 2026), +160.1% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
CYPH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.91 | 3.00 | 2.50 | 2.57 | 11.57M |
| Oct 15, 2026 | 2.42 | 3.09 | 2.38 | 3.02 | 16.44M |
| Oct 14, 2026 | 2.71 | 2.82 | 2.57 | 2.62 | 8.20M |
| Oct 13, 2026 | 2.79 | 2.84 | 2.70 | 2.84 | 7.40M |
| Oct 12, 2026 | 3.01 | 3.23 | 2.86 | 2.90 | 9.39M |
| Oct 9, 2026 | 2.97 | 3.17 | 2.88 | 2.94 | 10.26M |
| Oct 8, 2026 | 2.80 | 2.84 | 2.55 | 2.81 | 14.77M |
| Oct 7, 2026 | 2.97 | 3.09 | 2.93 | 3.05 | 8.11M |
| Oct 6, 2026 | 3.17 | 3.40 | 3.09 | 3.26 | 13.08M |
| Oct 5, 2026 | 3.01 | 3.19 | 2.88 | 3.17 | 14.39M |
| Oct 2, 2026 | 3.21 | 3.42 | 3.01 | 3.03 | 15.38M |
| Oct 1, 2026 | 3.13 | 3.27 | 2.91 | 2.92 | 15.69M |
| Sep 30, 2026 | 3.50 | 3.69 | 3.31 | 3.33 | 16.18M |
| Sep 29, 2026 | 3.34 | 3.51 | 3.14 | 3.23 | 13.57M |
| Sep 28, 2026 | 4.03 | 4.14 | 3.18 | 3.31 | 26.75M |
| Sep 25, 2026 | 3.96 | 4.19 | 3.82 | 4.12 | 19.97M |
| Sep 24, 2026 | 3.40 | 4.14 | 3.39 | 4.08 | 25.16M |
| Sep 23, 2026 | 3.82 | 3.98 | 3.49 | 3.61 | 19.77M |
| Sep 22, 2026 | 3.51 | 3.90 | 3.42 | 3.73 | 25.15M |
| Sep 21, 2026 | 4.00 | 4.02 | 3.38 | 3.40 | 21.46M |
About Cypherpunk Technologies
Cypherpunk Technologies (CYPH) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in CAMBRIDGE, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1509745.
CYPH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| James H Cavanaugh | Director | Mar 17, 2026 |
| Thomas John Dietz | Director | Aug 27, 2026 |
| Amanda Fabiano | Director | Sep 25, 2026 |
| William Li | Director | Jul 2, 2026 |
| Joseph Loscalzo | Director | Mar 17, 2026 |
| Patricia A. Martin | Director | Sep 25, 2026 |
| Nissim Mashiach | Director | Jul 2, 2026 |
| William Patrick Iii Mcevoy | Chief Investment Officer | Aug 19, 2026 |
| Christopher Mirabelli | Director | Mar 30, 2026 |
| Douglas E Onsi | CEO,CFO,Pres.,GC,Treas.&Sec. | Jul 2, 2026 |
| Khing Djien Oei | Director | Sep 25, 2026 |
| Christian M Richard | Director | Jul 2, 2026 |
| Richard Schilsky | Director | Mar 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| William Patrick Iii Mcevoy | Chief Investment Officer | Aug 19, 2026 |
| Douglas E Onsi | CEO,CFO,Pres.,GC,Treas.&Sec. | Jul 2, 2026 |
| Kevin Zhang | Head of Mining | Aug 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 25, 2026 | Khing Djien Oei | Sale | 168,750 | $3.92 |
| Sep 25, 2026 | Khing Djien Oei | Sale | 168,750 | $3.92 |
| Sep 25, 2026 | Khing Djien Oei | Sale | 168,750 | $3.92 |
| Sep 25, 2026 | Khing Djien Oei | Sale | 168,750 | $3.92 |
| Sep 23, 2026 | Patricia A. Martin | Sale | 50,000 | $3.86 |
| Sep 23, 2026 | Patricia A. Martin | Sale | 50,000 | $3.86 |
| Sep 23, 2026 | Patricia A. Martin | Sale | 50,000 | $3.86 |
| Sep 23, 2026 | Patricia A. Martin | Sale | 50,000 | $3.86 |
| Aug 26, 2026 | Thomas John Dietz | Sale | 20,000 | $1.72 |
| Aug 26, 2026 | Thomas John Dietz | Sale | 20,000 | $1.72 |
| Aug 26, 2026 | Thomas John Dietz | Sale | 20,000 | $1.72 |
| Aug 26, 2026 | Thomas John Dietz | Sale | 20,000 | $1.72 |
| Mar 26, 2026 | Christopher Mirabelli | Sale | 60,000 | $0.71 |
| Mar 26, 2026 | Christopher Mirabelli | Sale | 60,000 | $0.71 |
| Mar 26, 2026 | Christopher Mirabelli | Sale | 60,000 | $0.71 |
CYPH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $4.82M | 0.07 | $-43.90M |
| Dec 31, 2024 | β | $-67.56M | -1.81 | $-60.30M |
| Dec 31, 2023 | β | $-81.41M | -3.98 | $-43.75M |
| Dec 31, 2022 | β | $-54.60M | -4.82 | $-49.04M |
| Dec 31, 2021 | $1.50M | $-40.59M | -0.47 | $-35.16M |
Latest balance sheet: total assets $142.97M, total liabilities $3.65M, cash $7.62M (as of Jun 30, 2026).
CYPH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $0.66 |
| May 14, 2026 | 8-K Item 2.02 (results) | $1.20 |
| Mar 16, 2026 | 8-K Item 2.02 (results) | $0.70 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $2.05 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $0.24 |
| May 13, 2025 | 8-K Item 2.02 (results) | $0.40 |
| Mar 26, 2025 | 8-K Item 2.02 (results) | $0.45 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $3.00 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | β |
| May 13, 2024 | 8-K Item 2.02 (results) | β |
| Mar 18, 2024 | 8-K Item 2.02 (results) | β |
| Nov 13, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CYPH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.